StockData
Xylem Inc. logo

Xylem Inc. (XYL) stock analysis

XYLNYSEPumps & Pumping EquipmentFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 24/3029% below fair value
$94.03−1.08 (-1.14%)

Close on Nov 12, 2026Market cap $21.56BP/E 20.8Yield 1.70%

StockData Score

Prices as of Nov 11, 2026How the score works

Value6Growth4Performance4Health6Dividend4

Strong24 of 30 checks passed

Xylem passes 24 of the 30 checks behind our score. Each dot in the shape is one check — hover it for the numbers.

Valuation
6/6
Growth
4/6
Past performance
4/6
Financial health
6/6
Dividend
4/6

What stands out

  • Margin of safety over 20%

    The price is 28.5% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $95.11 is below our fair value estimate of $133.09.

  • Low debt

    Debt is 28.2% of shareholders' equity, under the 40% we consider low.

  • Earnings grew over 5 years

    Net income grew 30.4% a year on average over the last five fiscal years.

What to watch

  • Return on equity under 15%

    Return on equity was 10.1% over the last twelve months and averaged 10.1% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 9.0%, below the 10% that usually covers the cost of capital.

  • Earnings growth not accelerating

    Net income grew 14.1% over the last twelve months, against a 5-year average of 30.4% a year.

  • Growing slower than the industry

    Revenue grew 1.9% over the last twelve months; the General Industrial Machinery and Equipment median is 12.4%.

Valuation6/6
  • P/E below its 5-year median

    Xylem's P/E of 21.0 is below its own 5-year median of 38.7.

  • P/E below the industry

    Xylem's P/E of 21.0 is below the General Industrial Machinery and Equipment median of 26.9.

  • EV/EBITDA below its 5-year median

    Xylem's EV/EBITDA of 17.5 is below its 5-year median of 23.5.

  • P/B below the industry

    Xylem's price-to-book of 2.12 is below the General Industrial Machinery and Equipment median of 2.84.

  • Trading below fair value

    The share price of $95.11 is below our fair value estimate of $133.09.

  • Margin of safety over 20%

    The price is 28.5% below fair value, more than the 20% cushion we look for.

Growth4/6
  • Revenue growing 10%+ a year

    Revenue grew 17.8% a year over the last three fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 26.0% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew 14.1% over the last twelve months, against a 5-year average of 30.4% a year.

  • Growing slower than the industry

    Revenue grew 1.9% over the last twelve months; the General Industrial Machinery and Equipment median is 12.4%.

  • Guidance raised

    Xylem raised its full-year 2026 revenue outlook on Jul 28, 2026.

  • Gross margin improving

    Gross margin was 39.8% over the last twelve months, against 38.2% a year earlier.

Past performance4/6
  • Return on equity under 15%

    Return on equity was 10.1% over the last twelve months and averaged 10.1% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 9.0%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Xylem's return on equity of 10.1% is above the General Industrial Machinery and Equipment median of 9.9%.

  • Earnings grew over 5 years

    Net income grew 30.4% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 11.9% over the last twelve months, against a 5-year average of 8.8%.

  • Net margin above the industry

    Xylem's net margin of 11.9% is above the General Industrial Machinery and Equipment median of 8.0%.

Financial health6/6
  • Low debt

    Debt is 28.2% of shareholders' equity, under the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 104% five years ago to 28.2%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 43.9% of total debt.

  • Interest well covered

    Operating income covers interest expense 36.1 times.

  • Short-term assets cover short-term debts

    Current assets are 1.39 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 3.12; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    Xylem paid dividends worth 1.8% of the share price over the last twelve months.

  • Yield below Treasuries

    The 1.8% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Xylem yields 1.8%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 37.4% of net income.

  • Covered by free cash flow

    Dividends take 44.0% of free cash flow.

Scores of similar companies

Our estimate per share

$133.09

The share price is 29% below this estimate.

20%+ below
Near fair value
20%+ above
$95.11Price$133.09Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E32.8×38.7×26.9×$148.4747%
EV/EBITDA20.9×23.5×18.3×$115.6541%
P/B3.0×3.1×2.8×$132.6312%
Earnings powerleft out, too far from the others9.8% cost of equity––$35.76–
Fair value$133.09100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 38.7
  • General Industrial Machinery and Equipment median 26.9

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$312.00M
Value traded per 1% price move
$206.84M

Downside

Low risk

Typical loss in a bad month
12.9%
Volatility (annualized)
31%
Sharpe ratio, 1 year
-1.35
Beta to the S&P 500 (5Y)
0.99

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

38.5%+0.9 pts over 5 years

Operating margin

13.5%+6.0 pts over 5 years

Net margin

10.6%+5.4 pts over 5 years

See a number that looks wrong?